Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Wolfson

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Scientific Reports|December 21, 2016
Loss of miR-140 is a key risk factor for radiation-induced lung fibrosis through reprogramming fibroblasts and macrophagesNadire Duru, Yongshu Zhang, Ramkishore Gernapudi, et al.
The Journal of Biological Chemistry|May 18, 2017
Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma <i>in situ</i> through activation of TGFβ signalingPang-Kuo Lo, Yongshu Zhang, Yuan Yao, et al.
Breast Cancer Research and Treatment|March 19, 2015
Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancerRamkishore Gernapudi, Yuan Yao, Yongshu Zhang, et al.
Cancer Immunology Research|December 23, 2020
Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune-Tumor Interactions: Engage, Expand, EnableKellsye P Fabian, Anthony S Malamas, Michelle R Padget, et al.
Journal for Immunotherapy of Cancer|November 30, 2018
Immunotherapy utilizing the combination of natural killer- and antibody dependent cellular cytotoxicity (ADCC)-mediating agents with poly (ADP-ribose) polymerase (PARP) inhibitionKathleen E Fenerty, Michelle Padget, Benjamin Wolfson, et al.
Journal for Immunotherapy of Cancer|September 4, 2019
Correction to: Immunotherapy Utilizing the Combination of Natural Killer- and Antibody Dependent Cellular Cytotoxicity (ADCC)-Mediating Agents with Poly (ADP-ribose) polymerase (PARP) InhibitionKathleen E Fenerty, Michelle Padget, Benjamin Wolfson, et al.
Journal for Immunotherapy of Cancer|April 30, 2020
Overcoming hypoxia-induced functional suppression of NK cellsKristen Solocinski, Michelle R Padget, Kellsye P Fabian, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Scientific Reports|December 21, 2016
Loss of miR-140 is a key risk factor for radiation-induced lung fibrosis through reprogramming fibroblasts and macrophagesNadire Duru, Yongshu Zhang, Ramkishore Gernapudi, et al.
The Journal of Biological Chemistry|May 18, 2017
Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma <i>in situ</i> through activation of TGFβ signalingPang-Kuo Lo, Yongshu Zhang, Yuan Yao, et al.
Breast Cancer Research and Treatment|March 19, 2015
Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancerRamkishore Gernapudi, Yuan Yao, Yongshu Zhang, et al.
Cancer Immunology Research|December 23, 2020
Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune-Tumor Interactions: Engage, Expand, EnableKellsye P Fabian, Anthony S Malamas, Michelle R Padget, et al.
Journal for Immunotherapy of Cancer|November 30, 2018
Immunotherapy utilizing the combination of natural killer- and antibody dependent cellular cytotoxicity (ADCC)-mediating agents with poly (ADP-ribose) polymerase (PARP) inhibitionKathleen E Fenerty, Michelle Padget, Benjamin Wolfson, et al.
Journal for Immunotherapy of Cancer|September 4, 2019
Correction to: Immunotherapy Utilizing the Combination of Natural Killer- and Antibody Dependent Cellular Cytotoxicity (ADCC)-Mediating Agents with Poly (ADP-ribose) polymerase (PARP) InhibitionKathleen E Fenerty, Michelle Padget, Benjamin Wolfson, et al.
Journal for Immunotherapy of Cancer|April 30, 2020
Overcoming hypoxia-induced functional suppression of NK cellsKristen Solocinski, Michelle R Padget, Kellsye P Fabian, et al.
Pageof 3